Full-Time

Senior Clinical Lead

Posted on 8/20/2025

ProPharma Group

ProPharma Group

1,001-5,000 employees

Regulatory sciences consultant for life sciences

No salary listed

United States

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Demonstrated ability to perform CRA activities at an advanced level.
  • Demonstrated ability to lead a team of Clinical Operations professionals in the successful execution of clinical trials.
  • Demonstrated ability to develop and maintain effective relationships with study site personnel and a track record of positively influencing them to achieve study goals.
  • Experience managing/mentoring and developing junior staff.
  • Bachelor’s degree preferred. Candidates with equivalent combination of education, training, and experience will be considered.
  • 5 + years of experience working in clinical research is preferred, including clinical research associate experience.
  • Prior LCRA and/or Clinical Lead experience is preferred.
  • Excellent verbal and written communication skills; interpersonal and presentation skills are required.
  • Experience using Microsoft Office (Word, Excel, Power Point) applications to prepare charts, tables, forms, reports, and presentations.
  • Experience in working in eTMF, CTMS, EDC, DCT and overall systems that support conduct of clinical trials.
  • Extensive understanding of SOPs, Works Instructions, regional regulations, ICH Guidelines, and GCPs governing the conduct of clinical trials.
Responsibilities
  • Oversight and management of the investigator site management and monitoring activities and the clinical monitoring teams for the assigned studies during the startup, execution, and close out phase of the study.
  • Functions as the lead site management resource for the client, investigational site, and the internal study team.
  • Ensures all monitoring activities for assigned projects are conducted according to study plans, relevant processes, and standard operating procedures (SOPs), GCP/ICH guidelines and other applicable regulations.
  • Provides input and supports development of study specific training material, and as appropriate provides study-specific training for the assigned clinical monitoring teams.
  • Oversees quality of clinical monitoring deliverables to clients and may conduct Quality Co-monitoring visits to ensure data quality and monitoring performance metrics are being met and develop solutions to optimize performance.
  • Responsible for the review and approval of study monitors’ site visit reports for the investigational sites on assigned studies within appropriate process requirements.
  • Works closely with clinical project manager and contributes to development of the clinical study specific plans as assigned. This includes but is not limited to clinical monitoring plan. Also responsible for creating and updating study specific tools and templates related to clinical site management and monitoring.
  • Assures compliance with study monitoring plan and collaborates with cross functional teams to ensure timely site initiate process.
  • Leads and supports any study specific requirements related to site performance, including but not limited to patient recruitment, site payments, study material needs, etc.
  • Works closely with clinical project management team and provides status report for onsite initiations, enrollment, visit schedules, trip report completion and any other status report as per the company and/or project specific requirements.
  • Works closely with the clinical project management team and the cross functional teams while keeping them apprised of any issues and seeking guidance as needed.
  • Maintains timely and effective communication among team members and site personnel as assigned.
  • May be responsible for the supervision and administrative oversight of the direct reports within the company expected framework. The direct report personnel may be clinical research associates (CRAs) or any other clinical team members if deemed appropriate.
  • Other duties as assigned.

ProPharma Group provides regulatory sciences consulting and related services for drugs, biologics, medical devices, and diagnostics on a global scale. Its offerings cover the full lifecycle, from early development and clinical trials to regulatory approval and post-market activities. The company’s services include regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology, delivered by a team of over 2,500 professionals with more than 20 years of operation. ProPharma Group differentiates itself by providing expert, end-to-end regulatory and life sciences solutions across multiple product types and stages, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory and compliance challenges. The goal is to help clients bring safe and compliant products to market efficiently while maintaining ongoing lifecycle support.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Hyderabad office opened November 2025 taps India's $130B pharma growth by 2030.
  • Dawn Sherman appointed CEO September 2024 drives global expansion strategy.
  • CF Box partnership revolutionizes cell/gene therapy manufacturing support.

What critics are saying

  • IQVIA undercuts prices, eroding ProPharma's pharmacovigilance share in 12-24 months.
  • Parexel acquisition intensifies clinical research competition in 6-12 months.
  • FDA AI tools automate 30% of submissions, reducing consulting demand in 18-36 months.

What makes ProPharma Group unique

  • ProPharma delivers end-to-end regulatory sciences across drugs, biologics, and devices.
  • Over 2,500 professionals provide pharmacovigilance and clinical research expertise.
  • Acquired Clinres Farmacija in 2024 to enhance CRO capabilities in Europe.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

24%
Pagal Parrot Media Private Limited
Dec 11th, 2025
ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands operations with new office in Hyderabad. Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the pharmaceutical industry. Mindspace is also the first commercial business park in Hyderabad to receive a Gold rating from the Indian Green Building Council (IGBC). The prominent placement of the ProPharma logo atop the building underscores the company's growing presence and brand visibility in India.The expansion supports ProPharma's continued growth trajectory by providing capacity for additional team members across multiple service lines and creating a modern, collaborative environment designed to inspire innovation and connection. More than 70 employees participated in the inaugural celebration."This milestone represents an important step forward in ProPharma's global expansion," said Jason DeGoes, President, ProPharma. "Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams.""We're proud to establish a world-class workspace in Hyderabad - one designed to foster creativity, efficiency, and collaboration," added Pavan Hemadri, Director of Business Operations, ProPharma. "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."The new state-of-the-art facility features open, collaborative workspaces aligned with ProPharma's global culture of innovation and operational excellence. It also underscores ProPharma's long-term investment in India as a key hub supporting its worldwide operations.About ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, FSP solutions, and digital transformation, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate its partners' most high-profile drug and device programs. For more information about ProPharma, please visit propharmagroup.com.About Odyssey Investment PartnersOdyssey Investment Partners is a leading private equity investment firm with more than a 25-year history of partnering with skilled managers to transform middle-market companies into more efficient and diversified businesses with strong growth profiles. Odyssey makes majority-controlled investments in industries with a long-term positive outlook and favorable secular trends. For further information about Odyssey, please visit odysseyinvestment.com.Logo - https://www.pagalparrot.com/wp-content/uploads/2025/12/ProPharma_Group_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/propharma-expands-operations-with-new-office-in-hyderabad-302638474.html

CNHI
Oct 21st, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer

RALEIGH, N.C., Oct. 21, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that Brian Tuttle has been named Chief Financial Officer.

Kilgore News Herald
Oct 9th, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ - ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the prestigious CPHI Pharma Award for Regulatory and Compliance.

PR Newswire
Sep 30th, 2024
ProPharma Names Dawn Sherman Chief Executive Officer

RALEIGH, N.C., Sept. 30, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced that Dawn Sherman has been appointed Chief Executive Officer.

GlobalData
Sep 24th, 2024
Clinical Trials Arena Excellence Awards 2024: ProPharma

ProPharma, a global research consulting company headquartered in the US, has won two awards in the 2024 Clinical Trials Arena Excellence Awards, in the Business Expansion and M&A categories, celebrating its acquisition of the Croatia-based contract research organization (CRO), Clinres Farmacija.

INACTIVE